4575.T
Price:
$806
Market Cap:
$15.88B
CanBas Co., Ltd., a clinical stage biopharmaceutical company, develops therapeutics for cancer patients. It develops CBP501, a calmodulin-modulating peptide to treat various cancer; and CBS9106, a reversible exportin-1inhibitor that is in Phase I clinical trial for the treatment of solid tumors. The company has a collaboration alliance with Stemline Therapeutics, Inc. CanBas Co., Ltd. was incorporated in 2000 and is based in Numazu, Japan.
Industry
Biotechnology
IPO Date
2009-09-17
Stock Exchange
JPX
Ticker
4575.T
According to CanBas Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -43.12%. This represents a change of 293.96% compared to the average of -10.94% of the last 4 quarters.
The mean historical ROE of CanBas Co., Ltd. over the last ten years is -85.97%. The current -43.12% ROE has changed -49.84% with respect to the historical average. Over the past ten years (40 quarters), 4575.T's ROE was at its highest in in the December 2015 quarter at 0%. The ROE was at its lowest in in the June 2024 quarter at -28.01%.
Average
-85.97%
Median
-45.48%
Minimum
-341.29%
Maximum
0%
Discovering the peaks and valleys of CanBas Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 0%
Minimum Annual Increase = 0%
Minimum Annual ROE = -341.29%
| Year | ROE | Change |
|---|---|---|
| 2025 | -39.31% | -23.88% |
| 2024 | -51.65% | -19.79% |
| 2023 | -64.39% | -81.13% |
| 2022 | -341.29% | 181.48% |
| 2021 | -121.25% | -49.85% |
| 2020 | -241.78% | -Infinity% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
The current ROE of CanBas Co., Ltd. (4575.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-51.78%
5-year avg
-123.58%
10-year avg
-85.97%
CanBas Co., Ltd.’s ROE is greater than StemRIM (-25.26%), greater than Oncolys BioPharma Inc. (-104.02%), greater than CellSeed Inc. (-60.98%), greater than ReproCELL Incorporated (-3.17%), greater than RaQualia Pharma Inc. (-12.38%), greater than Medical Data Vision Co., Ltd. (-14.47%), greater than Japan Tissue Engineering Co., Ltd. (-7.11%), greater than NANO MRNA Co.,Ltd. (-27.51%), greater than Sunwels Co.,Ltd. (-32.50%), greater than MediciNova, Inc. (-23.12%),
| Company | ROE | Market cap |
|---|---|---|
| -25.26% | $16.16B | |
| -104.02% | $21.34B | |
| -60.98% | $8.46B | |
| -3.17% | $13.92B | |
| -12.38% | $28.13B | |
| -14.47% | $63.83B | |
| -7.11% | $18.68B | |
| -27.51% | $9.91B | |
| -32.50% | $11.22B | |
| -23.12% | $11.18B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CanBas Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CanBas Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CanBas Co., Ltd.'s ROE?
How is the ROE calculated for CanBas Co., Ltd. (4575.T)?
What is the highest ROE for CanBas Co., Ltd. (4575.T)?
What is the 3-year average ROE for CanBas Co., Ltd. (4575.T)?
What is the 5-year average ROE for CanBas Co., Ltd. (4575.T)?
How does the current ROE for CanBas Co., Ltd. (4575.T) compare to its historical average?